Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00965497 · ClinicalTrials.gov registry record · Phase 3
Escitalopram (Lexapro) for Depression MS or ALS
A Phase 3 study, sponsored by University of South Carolina.
- Completed
- Registry status
- Phase 3
- Development phase
- 13
- Enrollment target
NCT00965497 is a Phase 3 study that has completed, run by University of South Carolina. The registered enrollment target is 13 participants.
The verdict
NCT00965497, a Phase 3 study, has completed, sponsored by University of South Carolina.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 13 participants
- Enrollment target
Study Summary
The purpose of this study is to see if escitalopram (Lexapro) improves symptoms of major depressive disorder in patients who have ALS or MS.
Interventions
- DRUG escitalopram
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2009-07 |
| Est. Completion | 2010-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00965497
The ClinicalTrials.gov registry entry for NCT00965497 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Carolina, which has 157 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which escitalopram is the first listed.
NCT00965497 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00965497 about?
NCT00965497 is a clinical study titled "Escitalopram (Lexapro) for Depression MS or ALS". The purpose of this study is to see if escitalopram (Lexapro) improves symptoms of major depressive disorder in patients who have ALS or MS.
What is the current status of trial NCT00965497?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 13 participants. The study started on 2009-07. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00965497?
The interventions under investigation include: escitalopram (DRUG).
Who is sponsoring clinical trial NCT00965497?
This trial is sponsored by University of South Carolina, which has 157 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.